Micro-encapsulation differentially impacts probiotic effects on brain structure and function in an elderly population – A randomised placebo-controlled trial
We are thrilled to announce the publication of a new groundbreaking clinical trial, which investigates the critical role of AnaBio micro-encapsulation in the efficacy of probiotics on the aging brain!
Our new paper, titled: 'Micro-encapsulation differentially impacts probiotic effects on brain structure and function in an elderly population – a randomised placebo-controlled trial' is now published in Brain, Behavior, and Immunity.
Key Takeaways from the Study:
Encapsulation Matters: We found that micro-encapsulation of Lacticaseibacillus rhamnosus significantly impacted its effects on brain health compared to the non-encapsulated form.
Differential Impact: Micro-encapsulated probiotics led to significant differences in functional connectivity in brain regions related to visual processing and perception in elderly adults (ages 60-80).
Cognition & Serotonin: The encapsulated group showed significant time-group effects on processing speed and a significant impact on the distribution of peripheral serotonin, highlighting a modified gut-brain axis interaction.
This research underscores the crucial importance of our advanced micro-encapsulation technology in ensuring targeted delivery and maximising the therapeutic potential of probiotics.
